Celestra is building autonomous agents to enhance market research.
Drug discovery is accelerating. AI is helping researchers develop new treatments faster than ever.
Soon, we believe the bottleneck to drug development won't be discovery, but commercialization.
As more drugs pass FDA drug approval, slow and manual commercialization operations will become the limiting factor to accelerated drug development.
Today, market research takes months. Patient identification is imprecise, and commercial strategy relies on outdated data and consultant-driven intuition.
We're building AI agents to automate drug commercialization so new treatments can reach patients faster.
Our agents tackle the core problems that delay launch and adoption:
Market analysis: Real-time competitive and market intelligence
Patient identification: Faster, more accurate targeting using claims and EHR data
Commercial strategy: Data-driven pricing, positioning, and go-to-market decisions
Regulatory insights: Smarter navigation of approval and launch requirements
We don't replace commercial teams - we amplify them.
Our agents help teams make decisions in hours, not weeks. They replace static reports with live, data-driven insight and scale world-class commercial expertise across the organization.
We build alongside pharma and biotech teams to solve real-world bottlenecks.
If you want to help remove the barriers that keep treatments from reaching patients, we'd love to talk.